-Business Standard While allocations to several social sector schemes have been increased, concerns about the direction of the funds being ploughed remain The health and education sectors have trudged along the last two years awaiting direction that would be set through new policies the National Democratic Alliance government promised. In the absence of these guiding documents, most observers have been left to read the intermittent policy decisions like tea-leaves to guess the...

-The Hindu The Modi government must stop engaging U.S. bureaucrats as patent consultants and instead showcase the Indian patent statute as an exemplar for a balanced regime Earlier this month, the media reported that India “privately” assured the United States that it will not issue any more compulsory licenses. This report was reminiscent of a theory propounded by psychologist Lenore E. Walker in 1979 on abusive patterns in relationships. Four stages of abuse Walker...

-The Hindu Business Line MFIs are unable to address the needs of self-help groups. They have been hit by the falling growth of SHGs There has been a long-standing debate on the ability and effectiveness of the formal banking system as a vehicle for financial inclusion. The thrust has been to increase the number of small banks, as they play a very important role in the supply of credit to small business...

-The Economic Times   I will never make the mistake of discontinuing M(G)NREGA; because it is a living testimony of your failures. After 60 years of Independence you had to make people dig ditches — Prime Minister Narendra Modi. In that March 2015 speech in Parliament, Prime Minister Modi taunted the Congress Party that the rural job guarantee programme Mahatma Gandhi National Rural Employment Guarantee Scheme (MGNREGS) was required because of the party's...

-The Telegraph New Delhi: International humanitarian agency Medecins Sans Frontieres has filed an application to block US pharmaceutical company Pfizer from obtaining a patent in India for a vaccine against pneumonia and allow Indian vaccine manufacturers to make low-cost versions. The patent opposition moved by MSF has claimed that Pfizer's patent application, which describes methods of conjugating 13 serotypes (strains) of the bacterium Streptococcus pneumoniae into a single carrier vaccine, does not...